Substance-abuse - Articles - Page 4

Combining Alcohol With Caffeinated Energy Drinks Leads to Increased Alcohol Consumption

September 1, 2016

Bret A. Moore, PsyD, ABPP

Combining caffeine-based energy drinks and alcohol has become a popular practice among social drinkers over the past decade. Users say that the caffeine enhances their buzz and allows them to drink for longer periods of time.

Applying Dialectical Behavior Therapy to Addiction

August 1, 2016

Dialectical behavior therapy (DBT) is well-known for treating borderline personality disorder (BPD) and individuals at high risk for suicide. Two studies have shown that DBT has really good outcomes in terms of reducing substance use. In this interview, Dr. Linehan shares her knowledge of DBT as a treatment method for addiction.

Motivational Interviewing: Ten Tips

June 1, 2016

David Rosengren, PhD

Dr. Rosengren presents ten tips for motivational interviewing to help clinicians listen and help their clients struggling with addiction issues.

CLINICAL Q&A

Using Motivational Interviewing in Your Practice

June 1, 2016

David Rosengren, PhD

David Rosengren, PhD. President of Prevention Research Institute, Inc.
Dr. Rosengren has disclosed that he receives book royalties from Guilford Press. Dr. Carlat has reviewed this article and found no evidence of bias in this educational activity.

At its most basic, motivational interviewing is a conversation in which you are trying to help someone deal with ambivalence that prevents them from acting on a problematic behavior. At a more complex level, it has to do with things like paying attention to how the patient talks and what kind of language they’re using. In this interview, Dr. Rosengren discusses the language and process of motivational interviewing.

RESEARCH UPDATE

Synthetic THC and Antihypertensive Provide Little Benefit for Cannabis Dependence

May 1, 2016

Bret A. Moore, PsyD, ABPP

Bret A. Moore, PsyD, ABPP. Board-Certified Clinical Psychologist, San Antonio,.

Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Second only to alcohol, marijuana is the most common reason people enter substance abuse treatment. And unlike alcohol dependence, there are virtually no effective medications available for those addicted to it. It’s not from a lack of trying. A recent review of 14 drug studies for cannabis dependence revealed little benefit from antidepressants, anticonvulsants, or anxiolytics.

Addiction and Family: What You Need to Know

January 1, 2016

Alison Knopf

Alison Knopf.

Editor of Alcoholism & Drug Abuse Weekly, a subscription newsletter published by Wiley that focuses on policy and programming, and a freelance journalist specializing in mental health and substance use issues.

Ms. Knopf has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The addiction field has clearly become less enamored with terms such as codependency. This article brings you up to date on some tried and true approaches for working with the families of patients with substance use disorders.

Alcohol Addiction: The Role of Families in Treating Patients

January 1, 2016

Stephanie Brown, PhD

Stephanie Brown, PhD.

Dr. Brown is a licensed psychologist and expert on the treatment of alcoholics, adult children of alcoholics, and addicts and their families. Dr. Brown is the author of 11 academic and popular books on addiction and recovery, including Treating the Alcoholic: A Developmental Model of Recovery.

Dr. Brown has disclosed that she has no relevant financial or other interests in any commercial
companies pertaining to this educational activity.

Dr. Brown is a pioneer in understanding the interplay of family dynamics and addiction. She discusses addiction cases and how how family influences treatment methods for substance abuse.

Intranasal Naloxone Product Approved by FDA

January 1, 2016

Talia Puzantian, PharmD, BCPP

Talia Puzantian, PharmD, BCPP

Clinical psychopharmacology consultant, www.taliapuzantian.com

Dr. Puzantian has disclosed that she has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

The opioid antagonist, naloxone, was first approved for opioid overdose treatment in 1971 and is available as an inexpensive injectable generic. In recent years, emergency responders have been using more easily administered intranasal version of naloxone.

How Psychiatrists Can Use AA to Help Their Patients

November 1, 2015

Alison Knopf

The influence of the Twelve Steps recovery program of Alcoholics Anonymous (AA) is pervasive, but many psychiatrists treating patients with alcohol use—or other substance use—disorders may be unaware of exactly how it can help them in their work.